Enzolytics’s IPF Immune™ Dietary Supplement Will Soon Go Live on Amazon

Amazon will soon offer to its consumers IPF Immune™, a dietary supplement that supports the body’s self-defense system.

“We are excited about Amazon carrying our IPF Immune™,” said Charles S. Cotropia, CEO of Enzolytics, Inc. “Amazon is by far the largest online retailer in the United States. This will enable us to reach the millions of consumers who shop on Amazon.

“We are expecting to announce even more retailers in the future. OneLavi.com, a boutique health and wellness site, recently started selling IPF Immune™,” he added. “The vitamin and dietary supplement sector is gaining popularity every year. We think retailers will realize how good IPF Immune™ is and add it to their shelves.”

The Council for Responsible Nutrition, which publishes an annual survey on dietary supplement usage in the U.S., said its initial data for 2022 shows the number of American consumers buying  supplements has surpassed the 80 percent level for the first time.”

Mr. Cotropia said people are taking their health more seriously than ever before.

“Each generation seems to be more health conscious than their parents and grandparents,” he added.

Enzolytics IPF Immune™, which is gluten-free, is a nutritional supplement that is taken orally two consecutive days per week for eight consecutive weeks.

“Enzolytics IPF Immune™ helps support your immune system,” said Harry H. Zhabilov, Enzolytics’ Chief Scientific Officer. “We want to help people live longer, healthier, and happier lives.”

Enzolytics is a Texas-based biotechnology company committed to developing effective and affordable therapeutics for treating a variety of conditions.

“We are working on a variety of therapies that we hope will help people,” Mr. Zhabilov said. “IPF Immune™ is an over-the-counter supplement that people can take for added protection.”

To purchase IPF Immune™, please visit OneLavi.com.

Disclaimer: The statements made regarding these products have not been evaluated by the Food and Drug Administration. This press release is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please check with your doctor. The news site hosting this press release is not associated with Enzolytics, Inc. It is merely publishing a press release announcement submitted by a company, without any stated or implied endorsement of the product or service.

Company Contact:
Enzolytics, Inc.
1101 Raintree Circle
Allen, Texas 75013
SOURCE: Enzolytics, Inc

About Enzolytics, Inc.

Enzolytics Inc. is a Texas-based biotechnology company that focuses on therapeutics to treat numerous human health medical conditions. In addition to Enzolytics IPF Immune™, which will be on the U.S. market soon, the Company is developing other therapeutics for treating multiple infectious diseases.